FDA approves first Gene Therapies for patients with Sickle Cell Disease

Today FDA announced approval for the first gene therapies for patients with Sickle Cell Disease. “Sickle cell disease is a rare, debilitating and life-threatening blood disorder with significant unmet need, and we are excited to advance the field es...